Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Roma
Clinical trial register · Italy

Clinical Trials in Roma, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 138 Naples 80 Roma 72 Florence 57 Padova 56
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS197 AstraZeneca72 Novartis Pharmaceuticals52 Janssen Research & Development, LLC44 Merck Sharp & Dohme LLC43 Clear sponsor filter
Site location
Milan138 Naples80 Roma72 Florence57 Padova56
All 111 locations
Target enrolment
to

Trials with a site in Roma

72 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
AstraZeneca
Phase 3
1,072
Brescia, Cona, Florence, Milan, Roma
2026-08-31
Recruiting
AstraZeneca
Phase 3
2,500
Bologna, Milan, Palermo, Pisa, Roma, Rozzano, Sesto San Giovanni, Torino
2026-08-19
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
230
Roma
2026-07-24
Recruiting
AstraZeneca
Phase 3
915
Bari, Florence, Padova, Roma, Rozzano, Tricase
2026-07-16
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Recruiting
AstraZeneca
Phase 1/2
152
Bergamo, Meldola, Milan, Roma
2026-06-03
Recruiting
AstraZeneca
Phase 3
245
Brescia, Catania, Ferrara, Florence, Milan, Padova, Pisa, Roma
2026-04-13
Recruiting
AstraZeneca
Phase 2
124
Milan, Padua, Roma, Rozzano
2026-02-10
Recruiting
AstraZeneca
Phase 2
230
Modena, Naples, Palermo, Pisa, Roma, Varese
2025-12-10
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Milan, Orbassano, Pavia, Roma
2025-11-24
Recruiting
AstraZeneca
Phase 2
435
Milan, Palermo, Pavia, Perugia, Roma, Rozzano, Torrette
2025-11-06
Recruiting
AstraZeneca
Phase 3
100
Aviano, Florence, Meldola, Milan, Naples, Roma
2025-10-30
Recruiting
AstraZeneca
Phase 1/2
283
Milan, Naples, Roma, Rozzano
2025-10-01
Recruiting
AstraZeneca
Phase 2
278
Aviano, Catania, Meldola, Milan, Orbassano, Roma, Rozzano
2025-08-07
Recruiting
AstraZeneca
Phase 2
987
Busto Arsizio, Cuneo, Ferrara, Milan, Monza, Naples, Pavia, Roma
2025-06-27
Recruiting
AstraZeneca
Phase 3
150
Florence, Orbassano, Roma
2025-05-15
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
AstraZeneca
Phase 3
600
Catania, Florence, Milan, Monza, Naples, Reggio Emilia, Roma, Rome
2025-03-27
Recruiting
AstraZeneca
Phase 2
540
Catania, Foggia, Genoa, Roma
2025-03-26
Recruiting
AstraZeneca
Phase 3
990
Cona, Florence, Milan, Montebelluna, Naples, Pavia, Roma, Sassari
2025-03-18
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Active, closed
AstraZeneca
Phase 2
24
Padova, Roma, Rozzano
2024-12-11
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Alessandria, Bologna, Busto Arsizio, Milan, Roma
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,160
Florence, Legnano, Livorno, Monza, Orbassano, Padova, Peschiera del Garda, Roma
2024-11-18
Active, closed
AstraZeneca
Phase 3
310
Florence, Orbassano, Roma, Verona
2024-09-30
Active, closed
Phase IIa Study Evaluating AZD7798 in Crohn's Disease
NCT06450197Moderate to Severe Crohn's Disease
DrugAZD7798
AstraZeneca
Phase 2
120
Milan, Roma, Rome
2024-08-28
Recruiting
AstraZeneca
Phase 3
620
Florence, Milan, Naples, Padova, Roma, Rozzano, Tricase
2024-08-12
Active, closed
AstraZeneca
Phase 3
339
Brescia, Cona, Florence, Milan, Naples, Reggio Emilia, Roma, Rome
2024-06-29
Recruiting
AstraZeneca
Phase 3
675
Bergamo, Genoa, Milan, Monza, Padova, Pavia, Ravenna, Roma
2024-04-11
Recruiting
AstraZeneca
Phase 3
100
Florence, Genova, Milan, Padova, Roma
2024-03-14
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Bergamo, Bologna, Monza, Naples, Roma
2023-12-29
Recruiting
AstraZeneca
Phase 3
625
Bergamo, Empoli, Milan, Modena, Naples, Padova, Reggio Emilia, Roma
2023-11-23
Active, closed
AstraZeneca
Phase 3
1,902
Empoli, Lucca, Milan, Modena, Naples, Padova, Province of Macerata, Roma
2023-11-14
Active, closed
AstraZeneca
Phase 3
314
Ancona, Brescia, Cona, Milan, Padova, Roma
2023-11-08
Active, closed
AstraZeneca
Phase 3
1,835
Bergamo, Bologna, Foggia, Genoa, Naples, Pisa, Roma, Torino
2023-11-07
Active, closed
AstraZeneca
Phase 3
895
Bari, Bergamo, Milan, Padova, Parma, Pavia, Ravenna, Roma
2023-10-24
Recruiting
AstraZeneca
Phase 3
231
Genova, Pavia, Roma
2023-08-24
Active, closed
AstraZeneca
Phase 3
94
Milan, Roma
2023-04-05
Recruiting
AstraZeneca
Phase 3
3,527
Arezzo, Brescia, Naples, Roma, Rozzano, Torino
2022-12-13
Active, closed
AstraZeneca
Phase 3
368
Bologna, Milan, Naples, Padova, Pisa, Roma, Rozzano, Verona
2022-11-10
Active, closed
AstraZeneca
Phase 2
194
Candiolo, Milan, Naples, Padova, Perugia, Roma, Siena
2022-08-11
Active, closed
AstraZeneca
Phase 3
53
Messina, Naples, Roma
2022-07-01
Active, closed
PASS of Paediatric Patients Initiating Selumetinib
NCT05388370Neurofibromatosis Type 1
AstraZeneca
Observational
124
Florence, Genova, Milan, Padova, Pavia, Roma, Torino, Trieste
2022-05-23
Active, closed
AstraZeneca
Phase 3
760
Arezzo, Florence, Milan, Roma, Rozzano, Tricase
2022-03-28
Active, closed
AstraZeneca
Phase 3
791
Bergamo, Roma, Rozzano
2022-02-18
Active, closed
AstraZeneca
Phase 3
363
Ancona, Cona, Eboli, Padova, Roma
2022-02-15
Active, closed
AstraZeneca
Phase 3
1,051
Brescia, Florence, Lucca, Meldola, Orbassano, Parma, Pavia, Roma
2022-02-07
Active, closed
AstraZeneca
Phase 3
145
Milan, Naples, Roma
2021-11-19
Active, closed
AstraZeneca
Phase 3
454
Milan, Monza, Orbassano, Parma, Roma, Verona
2021-10-28
Active, closed
AstraZeneca
Phase 3
927
Bologna, Candiolo, Livorno, Milan, Naples, Negrar, Padova, Roma
2021-10-25
Recruiting
AstraZeneca
Phase 1/2
460
Milan, Modena, Roma
2021-10-18
Active, closed
AstraZeneca
Phase 3
98
Florence, Meldola, Messina, Naples, Padova, Roma, Terni, Verona
2021-09-12
Active, closed
AstraZeneca
Phase 3
712
Bari, Florence, Meldola, Milan, Padova, Pozzuoli, Reggio Emilia, Roma
2021-08-05
Active, closed
AstraZeneca
Phase 3
893
Bologna, Florence, Misterbianco, Naples, Padova, Prato, Roma
2021-05-10
Active, closed
AstraZeneca
Phase 1
155
Aviano, Meldola, Orbassano, Roma
2021-02-02
Active, closed
AstraZeneca
Phase 1/2
702
Milan, Modena, Naples, Padova, Roma
2020-11-12
Active, closed
AstraZeneca
Phase 2
452
Milan, Naples, Padova, Roma, Verona
2020-06-03
Active, closed
AstraZeneca
Phase 2
240
Bologna, Catanzaro, Meldola, Messina, Milan, Monza, Naples, Roma
2020-04-22
Active, closed
AstraZeneca
Phase 3
140
Cuneo, Florence, Milan, Naples, Roma, Torino
2019-10-29
Active, closed
AstraZeneca
Phase 3
908
Bologna, Milan, Naples, Roma, Tricase, Lecce, Verona
2019-04-29
Active, closed
AstraZeneca
Phase 3
810
Faenza, Florence, Milan, Naples, Roma, Verona
2019-04-16
Active, closed
AstraZeneca
Phase 3
724
Florence, Genova, Milan, Orbassano, Padova, Pavia, Roma, Rozzano
2019-03-06
Active, closed
AstraZeneca
Phase 3
825
Ancona, Bari, Bergamo, Florence, Milan, Monza, Padova, Roma
2018-12-06
Active, closed
AstraZeneca
Phase 3
730
Brescia, Milan, Orbassano, Parma, Roma, Rozzano, Terni
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,246
Arezzo, Milan, Naples, Orbassano, Parma, Pavia, Roma, Terni
2018-09-27
Active, closed
AstraZeneca
Phase 3
1,324
Benevento, Meldola, Milan, Naples, Perugia, Pisa, Roma, Rozzano
2017-10-11
Active, closed
Savolitinib vs. Sunitinib in MET-driven PRCC.
NCT03091192Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Urologic Neoplasms
DrugsSavolitinib·Sunitinib
AstraZeneca
Phase 3
60
Arezzo, Meldola, Milan, Modena, Orbassano, Pavia, Roma
2017-07-25
Active, closed
AstraZeneca
Phase 3
987
Bergamo, Meldola, Milan, Palermo, Roma, Terni
2017-03-27
Active, closed
AstraZeneca
Phase 3
1,126
Arezzo, Meldola, Milan, Naples, Orbassano, Pavia, Roma, San Giovanni Rotondo
2015-11-02
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Milan, Modena, Naples, Padova, Roma
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bari, Catania, Milan, Naples, Padova, Roma
2013-08-26
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 October 2026. https://priyalifescience.com/clinical-trials-italy/city/roma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Roma that also match the filters currently applied.

How many clinical trials are recruiting in Roma?

31 of the 72 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 41 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Roma), 72 studies
PhaseStudiesRecruitingShare
Phase 3511870.8%
Phase 213818.1%
Phase 1/2658.3%
Observational101.4%
Phase 1101.4%

Most active sponsors

Lead sponsors with the most studies (Roma)
Lead sponsorStudiesRecruiting
AstraZeneca7231
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.